Ateneo - UPO

1) the different compartments of the pharmaceutical industry; 2) required knowledge to engage in research and development; 3) required knowledge to engage in entrapreneurship in the pharmaceutical world; 4) examples of R&D of drugs that have been approved in the last 12 months

handouts distributed in the classroom, EPARs of the drugs approved by the European Medicines Agency (EMA), scientific literature

- illustrate to students the entire process of R&D, from the idea to the approval of regulatory bodies; - give students an entrepreneurship spirit, providing him with the basis to develop an idea in a start-up;

attendence of the General and Molecular Pharmacology course and the "Toxicology and laboratory of pharmacology" courses in the third year

- formal lectures; . flipped classroom; - expert testimonials; - practicals that will include literature searches and data presentation; -small classroom tutorials - For the COVID-19 epidemic, some lectures and some face-to-face meetings may be held by teleconference

Students with physical disabilities, Learning Disabilities or Special Education Needs can request specific services and tools via the Staff Sviluppo e Coordinamento Carriere e Servizi alle Studentesse e agli Studenti, consulting the University webpage: https://www.uniupo.it/en/services/services-students-physical-or-learning-disabilities
Students with disabilities, learning disabilities or special education needs, once they have contacted the University Staff, can refer to the tutor in charge of the course to define the examination modalities, concerning academic aspects.

Evaluation will be done in two different modalities: (1) a multiple choice test to evaluate the knowledge delivered during the lectures; (2) oral presentation of a start-up idea for the development of a drug;

1) the different divisions of the pharmaceutical industry: R&D, medical affairs, regulatory affiars, sales, market access; 2) preclinical in vivo and in vitro models in drug discovery; 3) clinical trials; 4) examples of R&D of drugs licensed in the last 12 months from the www.ema.europa.eu; 5) intellectual property and patent rights; 6) fund-raising; 7) efficacious oral presentations (pitches); 8) hit and lead candidates; 9) small chemical entities, biotech drugs, and advanced therapies; 10) the pharmaceutical market, unmet clinical needs and willingness to pay

1) ability to present ideas efficiently; 2) ability to develop a strategy for drug development; 3) ability to integrate in an industrial context; 4) ability to devise strategies for fund-raising in the pharmaceutical context.